Guidelines

AGA: Recommendations for Monitoring Drug Therapy in IBD

By August 14, 2017

To optimize drug concentration and improve outcomes, therapeutic drug monitoring is used to check the trough concentration and evaluate for the presence of anti-drug antibodies.

ACOG: Recommendations for Counseling Teens About Contraception

July 27, 2017

Ob-gyns should address contraceptive needs, expectations, and concerns, regardless of patient age

USPSTF Issues Draft Recommendation Statement on Ovarian Cancer Screening

July 21, 2017

Test isn't accurate enough to justify its use, U.S. Preventive Services Task Force says

PANS/PANDAS Treatment Guidelines Released

By July 20, 2017

"Immunomodulatory therapy should be considered early, because NSAIDs or a short course of oral corticosteroids may be sufficient for symptom remission in recent-onset cases, whereas those with long-standing symptoms often require more intensive and prolonged immunotherapeutic interventions," the authors write.

Guidance Document Revises Management Practices in NAFLD

July 19, 2017

Pharmacologic treatments aimed at improving liver disease should be limited to those with biopsy-proven nonalcoholic liver steatohepatitis (NASH) and fibrosis.

Task Force Issues New CRC Screening Recommendations

By June 21, 2017

Individuals with a family history of CRC in a first-degree relative diagnosed before age 60 should undergo colonoscopy every 5 years beginning at age 40 or 10 years before the age at which their relative was diagnosed.

USPSTF Updates Obesity Screening Recommendations for Children

June 21, 2017

B recommendation supports screening for children and adolescents aged 6 and older

NAMS: New Position Statement on Hormone Therapy

By June 20, 2017

Firstly, NAMS reiterates that HT should be individualized for each patient and requires periodic reevaluation for risks and benefits of selected therapy.

Recommendations for Handling In-Flight Cardiac Arrest Proposed

By June 05, 2017

Emergency equipment should be available and its location should be mentioned in the pre-flight safety announcement.

USPSTF Issues Statement on Adolescent Idiopathic Scoliosis Screening

May 31, 2017

USPSTF finds insufficient evidence to assess benefits, harms of screening asymptomatic 10- to 18-year-olds

AAP: Policy Statement Regarding Fruit Juice Consumption

By May 22, 2017

The AAP also states that human milk or infant formula is sufficient for infants whereas low-fat/nonfat milk and water are sufficient for older children.

AACE/ACE: New ACP Osteoporosis Guidelines 'Fall Short'

By May 19, 2017

Five important differences were identified by AACE/ACE involving pharmacotherapy choice as well as treatment duration and reevaluation.

ACP: Low Bone Density, Osteoporosis Treatment Recommendations

May 12, 2017

Osteoporotic women should be treated with pharmacologic therapy for 5 years to cut fracture risk

EAACI: Position Paper on Non-Allergic Rhinitis Management

May 11, 2017

The authors note that diagnosis of NAR is based on a detailed medical history and exclusion of clinically relevant sensitization to airborne allergens, and exclusion of clinical signs of rhinosinusitis.

USPSTF Issues Recommendation on Thyroid Cancer Screening

May 10, 2017

U.S. Preventive Services Task Force reaffirms guidelines it issued in 1996 and 2016

USPSTF Issues Statement on Preeclampsia Screening

April 26, 2017

Grade B recommendation suggests substantial net benefit for screening for pre-eclampsia

Guidelines on Sudden Unexpected Death in Epilepsy Released

By April 25, 2017

The greatest risk factor for SUDEP was found to be generalized tonic-clonic seizures (GTCS), with a higher frequency of these types of seizures correlating to an increased risk of death.

AATS Releases Guidelines for Empyema Management

By April 21, 2017

The guidelines include information on disease presentation, diagnosis, and treatment.

CDC Issues Shigella Management Recommendations

By April 21, 2017

The CDC has identified an increase in Shigella isolates with minimum inhibitory concentration (MIC) values of 0.12-1μg/mL for the fluoroquinolone antibiotic ciprofloxacin.

EASL: 2017 HBV Infection Management Guidelines

By April 20, 2017

The updated guidelines include new definitions of disease phases, expanded indications for initiating treatment and recommendations for special populations.

EASL Issues Guidelines on Primary Biliary Cholangitis Management

By April 19, 2017

EASL recommends the use of oral ursodeoxycholic acid at 13—15mg/kg/day as first-line treatment for patients with primary biliary cholangitis; treatment is usually continued for life.

ASCO: Pancreatic Cancer Treatment Update

April 17, 2017

Regimen of gemcitabine, capecitabine preferred in absence of concerns for toxicity, tolerance

USPSTF Issues Statement on Celiac Disease Screening

By March 28, 2017

Overall, the Task Force did not find enough evidence on the accuracy of screening for celiac disease in asymptomatic patients.

AHA/ACC Guidelines for Valvular Heart Disease Management Updated

March 22, 2017

Updated recommendations include modified recommendations for TAVR and surgical AVR

ASCO: HPV Vaccination Recommendations for Cervical Cancer Prevention

By March 20, 2017

The clinical practice guideline is the first for primary prevention of cervical cancer that is adapted to various areas in the world with different levels of socio-economic and structural resource settings.

New Sleep Apnea Management Guidelines Issued

By March 15, 2017

Six recommendations were developed to guide clinicians in diagnosing obstructive sleep apnea.

ADA: Synopsis of Recommendations for Diabetes Management

March 14, 2017

The ADA recommends metformin as first-line therapy for type 2 diabetes.

USPSTF Weighs In on Screening with Pelvic Examination

March 08, 2017

No direct evidence for benefits or harms of pelvic exam as a one-time or periodic screening test

Guidelines for Benign Paroxysmal Positional Vertigo Management Updated

March 06, 2017

New evidence was included from two clinical practice guidelines, 20 systematic reviews, and 27 randomized controlled trials.

USPSTF: Amblyopia Screening Should Occur Before Age 5

March 01, 2017

Young children should be screened at least once for amblyopia before they turn 5 years old, according to a draft recommendation statement issued by the U.S. Preventive Services Task Force.